References
- Oger J, Frykman H. An update on laboratory diagnosis in myasthenia gravis. Clin Chim Acta. 2015;449:43–8.
- Luckman SP, Skeie GO, Helgeland G, Gilhus NE. Morphological effects of myasthenia gravis patient sera on human muscle cells. Muscle Nerve. 2006;33:93–103.
- Jacob S, Viegas S, Leite MI, et al. Presence and pathogenic relevance of antibodies to clustered acetylcholine receptor in ocular and generalized myasthenia gravis. Arch Neurol 2012;69:994–1001.
- Gilchrist JM. Overview of neuromuscular disorders affecting respiratory function. Semin Respir Crit Care Med. 2002;23:191–200.
- Gilbert ME, Savino PJ. Ocular myasthenia gravis. Int Ophthalmol Clin. 2007 Fall;47:93–103 ix.
- Tamburrini A, Tacconi F, Barlattani A, Mineo TC. An update on myasthenia gravis, challenging disease for the dental profession. J Oral Sci. 2015;57:161–168.
- Engel AG, Shen XM, Selcen D, Sine SM. Congenital myasthenic syndromes: pathogenesis, diagnosis, and treatment. Lancet Neurol. 2015;14(5):420–434.
- Ortiz S, Borchert M. Long-term outcomes of pediatric ocular myasthenia gravis. Ophthalmology. 2008;115:1245–1248. e1
- Furlund Owe J, Skulstad Davidsen E, Eide GE, Gerdts E, Gilhus NE. Left ventricular long-axis function in myasthenia gravis. J Neurol. 2008;255:1777–1784.
- Reimann J, Jacobson L, Vincent A, Kornblum C. Endplate destruction due to maternal antibodies in arthrogryposis multiplex congenita. Neurology. 2009;73:1806–1808.
- Roth CK, Dent S, McDevitt K. Myasthenia gravis in pregnancy. Nurs Womens Health. 2015;19:248–252.
- Hoff JM, Daltveit AK, Gilhus NE. Myasthenia gravis in pregnancy and birth: identifying risk factors, optimising care. Eur J Neurol. 2007;14:38–43.
- Norwood F, Dhanjal M, Hill M, et al. Myasthenia in pregnancy: best practice guidelines from a UK multispecialty working group. J Neurol Neurosurg Psychiatry. 2014;85:538–543.
- Maddison P. Myasthenia gravis and pregnancy: pressing time for best practice guidelines. J Neurol Neurosurg Psychiatry. 2014;85:477.
- Oskoui M, Jacobson L, Chung WK, et al. Fetal acetylcholine receptor inactivation syndrome and maternal myasthenia gravis. Neurology. 2008;71:2010–2012.
- Niks EH, Verrips A, Semmekrot BA, et al. A transient neonatal myasthenic syndrome with anti-musk antibodies. Neurology. 2008;70:1215–1216.
- Ferrero S, Pretta S, Nicoletti A, Petrera P, Ragni N. Myasthenia gravis: management issues during pregnancy. Eur J Obstet Gynecol Reprod Biol. 2005;121:129–138.
- Cheng I, Lin CH, Lin MI, Lee JS, Chiu HC, Mu SC. Outcome of myasthenia gravis mothers and their infants. Acta Paediatr Taiwan. 2007;48:141–145.
- Saint-Faust M, Perelman S, Dupont D, Velin P, Chatel M. Transient neonatal myasthenia gravis revealing a myasthenia gravis and a systemic lupus erythematosus in the mother: case report and review of the literature. Am J Perinatol. 2010;27:107–110.
- Eymard B. Antibodies in myasthenia gravis]. Rev Neurol (Paris). 2009;165:137–143.
- Qi QW, Wang D, Liu JT, Bian XM. Management of pregnancy with myasthenia gravis: 7 cases report]. Zhonghua Fu Chan Ke Za Zhi. 2012;47:241–4.
- D'Amico A, Bertini E, Bianco F, et al. Fetal acetylcholine receptor inactivation syndrome and maternal myasthenia gravis: a case report. Neuromuscul Disord. 2012;22:546–548.
- Jayawant S, Parr J, Vincent A. Autoimmune myasthenia gravis. Handb Clin Neurol. 2013;113:1465–1468.
- Ramirez C, de Seze J, Delrieu O, Stojkovic T, Delalande S, Fourrier F, Leys D, Defebvre L, Destée A, Vermersch P. [Myasthenia gravis and pregnancy: clinical course and management of delivery and the postpartum phase]. Rev Neurol (Paris). 2006;162:330–338.
- Gajda A, Szabó H, Gergev G, Karcagi V, Szabó N, Endreffy E, Túri S, Sztriha L. Congenital myasthenic syndromes and transient myasthenia gravis. Ideggyogy Sz. 2013;66:200–203.